Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells

International Journal of Molecular Medicine

Volumn 29, Issue 2, 2012, Pages 225-230

  Lee, Sook Ja ^a   Jang, Haerim ^a   Park, Chaehwa ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Acetylation; Apoptosis; Bax; Ku70; Maspin

Indexed keywords

HISTONE DEACETYLASE 1; KU ANTIGEN; MASPIN; PROTEIN BAX;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG PROTEIN BINDING; HELA CELL; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ACETYLATION; ANTIGENS, NUCLEAR; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE, TUMOR; CYTOPLASM; DNA-BINDING PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; LYSINE; NEOPLASMS; PROTEIN BINDING; PROTEIN TRANSPORT; SERPINS;

EID: 84855185416     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.833     Document Type: Article

References (25)

1. Cher ML, Biliran HR Jr, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M and Sheng S: Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci USA 100: 7847-7852, 2003. (Pubitemid 36760058)
2. Zhang M, Shi Y, Magit D, Furth PA and Sager R: Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene 19: 6053-6058, 2000. (Pubitemid 32039379)
3. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ and Sager R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674, 1996. (Pubitemid 26347180)
4. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994. (Pubitemid 24082753)
5. Jiang N, Meng Y, Zhang S, Mensah-Osman E and Sheng S: Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21: 4089-4098, 2002. (Pubitemid 34712876)
6. Latha K, Zhang W, Cella N, Shi HY and Zhang M: Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol 25: 1737.1748, 2005.
7. Zhang W, Shi HY and Zhang M: Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer 5: 50, 2005.
8. Liu J, Yin S, Reddy N, Spencer C and Sheng S: Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 64: 1703.1711, 2004.
9. Bliss TM and Lane DP: Ku selectively transfers between DNA molecules with homologous ends. J Biol Chem 272: 5765-5773, 1997. (Pubitemid 27102407)
10. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA and Matsuyama S: Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5: 320-329, 2003. (Pubitemid 36432296)
11. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R, Ploegh H, Kessler BM and Sinclair DA: Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13: 627-638, 2004. (Pubitemid 38368121)
12. Li X, Yin S, Meng Y, Sakr W and Sheng S: Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res 66: 9323-9329, 2006. (Pubitemid 44521155)
13. Jang HL, Nam E, Lee KH, Yeom S, Son HJ and Park C: Maspin polymorphism associated with susceptibility to apoptosis and in vivo tumorigenesis. Int J Mol Med 22: 333-338, 2008.
14. Ngamkitidechakul C, Warejcka DJ, Burke JM, O'Brien WJ and Twining SS: Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. J Biol Chem 278: 31796-31806, 2003. (Pubitemid 37048361)
15. Subramanian C, Opipari AW Jr, Bian X, Castle VP and Kwok RP: Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 102: 4842-4847, 2005. (Pubitemid 40471541)
16. Li M, Luo J, Brooks CL and Gu W: Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611, 2002. (Pubitemid 36042220)
17. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H and Domann FE: Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31: 175-179, 2002.
18. Kim S, Han J, Kim J and Park C: Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 64: 6900-6905, 2004. (Pubitemid 39330997)
19. Dietmaier W, Bettstetter M, Wild PJ, Woenckhaus M, Rummele P, Hartmann A, Dechant S, Blaszyk H, Pauer A, Klinkhammer-Schalke M and Hofstadter F: Nuclear maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int J Cancer 118: 2247-2254, 2006.
20. Wilson CR, Davidson SE, Margison GP, Jackson SP, Hendry JH and West CM: Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer 83: 1702-1706, 2000. (Pubitemid 32001717)
21. Gu Y, Jin S, Gao Y, Weaver DT and Alt FW: Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci USA 94: 8076-8081, 1997. (Pubitemid 27343779)
22. Li GC, He F, Shao X, Urano M, Shen L, Kim D, Borrelli M, Leibel SA, Gutin PH and Ling CC: Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res 63: 3268-3274, 2003. (Pubitemid 36735882)
23. Celli GB, Denchi EL, de Lange T: Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol 8: 885-890, 2006. (Pubitemid 44151593)
24. Gu Y, Seidl KJ, Rathbun GA, Zhu C, Manis JP, van der Stoep N, Davidson L, Cheng HL, Sekiguchi JM, Frank K, Stanhope-Baker P, Schlissel MS, Roth DB and Alt FW: Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7: 653-665, 1997. (Pubitemid 28156633)
25. Ryu SW, Chae SK and Kim E: Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9. Biochem Biophys Res Commun 279: 6-10, 2000.